MARIOTTI, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 346.051
NA - Nord America 17.260
AS - Asia 2.901
AF - Africa 42
SA - Sud America 39
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 18
Totale 366.336
Nazione #
IT - Italia 340.134
US - Stati Uniti d'America 17.114
UA - Ucraina 2.062
CN - Cina 2.050
SE - Svezia 1.134
GB - Regno Unito 605
DE - Germania 547
FR - Francia 534
FI - Finlandia 475
SG - Singapore 437
CA - Canada 120
IN - India 108
KR - Corea 73
NL - Olanda 67
PL - Polonia 66
BE - Belgio 54
RU - Federazione Russa 50
VN - Vietnam 48
CH - Svizzera 46
RO - Romania 46
TR - Turchia 45
AL - Albania 40
SM - San Marino 36
ES - Italia 28
IR - Iran 26
EU - Europa 22
ID - Indonesia 19
IE - Irlanda 17
MU - Mauritius 16
EG - Egitto 15
GR - Grecia 15
AU - Australia 14
HK - Hong Kong 14
IQ - Iraq 13
MX - Messico 13
BR - Brasile 12
JP - Giappone 12
EC - Ecuador 11
HU - Ungheria 10
IL - Israele 10
RS - Serbia 10
PT - Portogallo 9
AE - Emirati Arabi Uniti 7
AT - Austria 7
DK - Danimarca 7
LT - Lituania 7
NO - Norvegia 7
PE - Perù 7
BA - Bosnia-Erzegovina 6
CL - Cile 6
BD - Bangladesh 5
CZ - Repubblica Ceca 5
BG - Bulgaria 4
CR - Costa Rica 4
JO - Giordania 4
KZ - Kazakistan 4
MC - Monaco 4
NZ - Nuova Zelanda 4
PH - Filippine 4
PK - Pakistan 4
TH - Thailandia 4
UZ - Uzbekistan 4
DZ - Algeria 3
HR - Croazia 3
LU - Lussemburgo 3
MD - Moldavia 3
MK - Macedonia 3
PA - Panama 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BY - Bielorussia 2
EE - Estonia 2
GE - Georgia 2
HN - Honduras 2
KE - Kenya 2
PY - Paraguay 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AR - Argentina 1
BH - Bahrain 1
BZ - Belize 1
CU - Cuba 1
LK - Sri Lanka 1
MA - Marocco 1
MT - Malta 1
NG - Nigeria 1
SC - Seychelles 1
SD - Sudan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 366.336
Città #
Cagliari 315.309
Rome 2.391
Fairfield 2.039
Woodbridge 1.898
Chandler 1.649
Milan 1.564
Houston 1.329
Ann Arbor 1.064
Jacksonville 989
Wilmington 975
Ashburn 973
Nyköping 780
Seattle 744
Cambridge 671
Naples 506
Boardman 453
Dearborn 436
Bologna 424
Nanjing 372
Florence 357
Beijing 294
Boston 290
Catania 286
Bari 276
Turin 262
Palermo 247
Helsinki 217
Shanghai 186
Singapore 179
Padova 161
New York 159
Verona 144
Genoa 140
Shenyang 121
San Diego 116
Hebei 113
Mountain View 103
Nanchang 103
Jiaxing 101
Toronto 98
Brescia 91
Parma 91
Guangzhou 88
Redwood City 88
Pisa 86
Pescara 84
Hangzhou 74
Livorno 73
Messina 71
Sassari 69
Reggio Emilia 68
Seoul 67
Changsha 66
Napoli 66
Venice 66
Torino 65
Los Angeles 63
Salerno 60
Tianjin 60
Vicenza 58
Atlanta 55
Orange 55
San Mateo 54
Zhengzhou 54
Perugia 53
Monza 50
Taranto 49
Dong Ket 48
Jinan 47
Lucca 47
Norwalk 46
Falls Church 45
Ningbo 45
Auburn Hills 41
Reggio Calabria 41
Modena 40
Genova 37
Brussels 36
London 36
Rimini 36
Trento 34
Hefei 33
Lecce 33
Ancona 32
Bergamo 32
Foggia 32
Treviso 32
Trieste 32
Ravenna 31
Spin 31
Augusta 30
Pune 30
Quartu Sant'Elena 30
Udine 30
Washington 30
Formigine 29
Taizhou 29
Oristano 28
Avellino 27
Sestu 27
Totale 341.500
Nome #
Thyroid diseases cause mismatch between MIBI scan and neck ultrasound in the diagnosis of hyperfunctioning parathyroids: usefulness of FNA–PTH assay 19.908
Dosaggio della tireoglobulina nell’aspirato dei linfonodi del comparto centrale per l’identificazione intraoperatoria delle metastasi da carcinoma differenziato della tiroide. 10.723
Ricerca di galectina-3, HBME-1 e grading delle atipie nell’agoaspirato dei noduli tiroidei con citologia indeterminata: risultati preliminari. 7.727
VGF peptide profiles in Type 2 diabetic patients' plasma and in obese mice 4.503
L’iperplasia delle cellule “c” parafollicolari senza mutazione del protooncogene ret: descrizione e implicazioni diagnostiche di alcuni casi clinici. 4.448
Assessing RET/PTC in thyroid nodule fine-needle aspirates: the FISH point of view 3.752
Optimizing detection of RET and PPARg rearrangements in thyroid neoplastic cells using a home-brew tetracolor probe 3.592
Hurthle tumors: a class of thyroid malignancy with massive chromosome disturbance 3.587
Prediction of type 1 diabetes in Sardinian schoolchildren using islet cell autoantibodies: 10-year follow-up of the Sardinian schoolchildren type 1 diabetes prediction study 3.578
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib: preliminary results from a single prospective cohort study. 3.548
Subclinical ocular alterations in thyroid eye disease. An additional score to predict the progression of disease 3.289
Subclinical alterations of extraocular muscles in Graves' Disease 3.265
Dosaggio della tireoglobulina (TG) negli agoaspirati linfonodali in pazienti con anticorpi anti-Tg (TgAb) circolanti. 2.990
Assessment of eating disorders with the diabetes eating problems survey - revised (DEPS-R) in a representative sample of insulin-treated diabetic patients: a validation study in Italy 2.929
Associazione tra carcinoma papillare della tiroide e tiroidite cronica autoimmune: nuove conferme da un ampio studio prospettico. 2.920
Cortical adrenal mitochondrial morphology changes in functional state: new insights 2.913
Reduction of Total Brain and Cerebellum Volumes Associated With Neuronal Autoantibodies in Patients With APECED 2.899
Assessing RET gene breakage in thyroid fine needle aspiration by fish: advantages and limits 2.894
High prevalence of papillary thyroid carcinoma in nodular Hashimoto's thyroiditis at the first diagnosis and during the follow-up 2.867
Metabolomic profile in hyperthyroid patients before and after antithyroid drug treatment: Correlation with thyroid hormone and TSH concentration 2.731
Differentiated thyroid cancer: indications and extent of central neck dissection--our experience. 2.725
Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link? 2.723
Association between autoimmune thyroiditis and papillary thyroid carcinoma: new confirmations from a large prospective study. 2.714
Novel neuronal and endocrine autoantibody targets in autoimmune polyendocrine syndrome type 1 2.661
Risultati di un ampio studio prospettico sull’associazione tra la tiroidite di Hashimoto e il carcinoma papillare della tiroide. 2.657
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib. Results from a single centre prospective cohort study. 2.641
RET/PTC rearrangements in hashimoto’s thyroiditis nodules: contribution to an ongoing debate. 2.635
Intertriginous and seborrheic dermatitis-like lesions in an endocrine patient 2.587
Predictive factors of malignancy in follicular thyroid nodules (THY3): Our experience on 324 patients 2.516
Score ecografico del rischio di malignità dei noduli tiroidei (TI-RADS): risultati citologici di uno studio prospettico di noduli con tiroidite di Hashimoto vs noduli senza tiroidite di Hashimoto. 2.487
Anterior pituitary autoantibodies in patients with type 1 diabetes mellitus: methodological problems and clinical correlations 2.475
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.406
Primary thyroid leiomyosarcoma: a case report and review of the literature 2.371
Diagnosi differenziale del nodulo tiroideo: la calcemia non è mai utile? 2.370
Thyroid Autoimmunity and Thyroid Cancer: Review Focused on Cytological Studies 2.334
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.301
Thyroid autoimmunity and thyroid cancer: pathological and molecular study in a longitudinal series of unselected nodules. 2.283
Thyroid imaging reporting and data system score: evaluation of risk stratification in thyroid nodules with Hashimoto’s Thyroiditis and thyroid nodules without Hashimoto’s thyroiditis underwent fine-needle aspiration cytology: results from a prospective study. 2.279
Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report 2.256
Utilità della scintigrafia con 99MTC-SestaMIBI nella diagnosi e nella gestione della tireotossicosi indotta da amiodarone. 2.254
Thyroid imaging reporting and data system score: evaluation of risk stratification in thyroid nodules with Hashimoto’s Thyroiditis and thyroid nodules without Hashimoto’s thyroiditis underwent fine-needle aspiration cytology: results from a prospective study. 2.249
Amiodarone-induced thyrotoxicosis. A review 2.245
High prevalence of male hypogonadism and sexual dysfunction in long-term clinically stable heart transplantation recipients. 2.213
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. Risultati di uno studio prospettico. 2.208
Prevalence of Type 1 diabetes autoantibodies (GAD and IA2) in Sardinian children and adolescents with autoimmune thyroiditis 2.199
Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis 2.156
RET/PTC rearrangements in Hashimoto’s thyroiditis nodules 2.152
Fifteen-year follow-up of thyroid function in lithium patients 2.131
A genetic epidemiology study of congenital adrenal hyperplasia in Italy 2.117
Autoimmunita’ tiroidea e carcinoma della tiroide: studio prospettico citologico, molecolare e istologico. 2.107
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. 2.095
Thyroid dysfunction in patients with metastatic carcinoma treated with Sunitinib: is thyroid autoimmunity involved? 2.089
RET/PTC rearrangement in Hashimoto’s thyroiditis nodules: contribution to an ongoing debate. 2.086
Brain perfusion abnormalities in patients with euthyroid autoimmune thyroiditis 2.085
HYPOTHYROIDISM AND THYROID AUTOIMMUNITY AS A PROGNOSTIC BIOMARKER OF BETTER RESPONSE IN METASTATIC CANCER LONG SURVIVORS TREATED WITH SUNITINIB 2.075
The birth and rise of a craniopharyngioma: the radiological evolution of an incidental craniopharyngioma detected on serial MRI during medical treatment of a macroprolactinoma 2.075
RET/PTC rearrangements in unselected nodules from patients with Hashimoto’s thyroiditis 2.064
Both thyroid autoimmunity and increased serum TSH are independent risk factors for malignancy in patients with thyroid nodules 2.058
Riarrangiamenti RET/PTC in noduli insorti in tiroidite d’Hashimoto 2.049
RET/PTC rearragements in Hashimoto’s thyroiditis nodules. 2.015
Higher prevalence of thyroid cancer in patients with thyroid nodules (TN) and Hashimoto’s Thyroiditis (HT) at the first clinical evaluation compared to TN patients without thyroid autoimmunity and HT patients without TN followed-up for 1-9 years. 2.004
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study 1.979
3-D structure of mitochondrial cristae in rat adrenal cortex varies after acute stimulation with ACTH and CRH 1.960
The diagnostic value of parathyroid assay in wash-out fluid from fine needle aspiration biopsy of neck masses in primary hyperparathyroid patients with uncertain 99mTC-SESTAMIBI scintigraphy. 1.899
Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features 1.887
Ipotiroidismo e autoimmunità tiroidea in pazienti affetti da carcinoma renale metastatico trattati con sunitinib con un follow-up di 30 mesi. 1.880
Risultati preliminari di uno studio longitudinale in pazienti affetti da morbo di Basedow con alterazioni subcliniche dei muscoli oculari. 1.823
Prevalence of thyroid cancer in patients with hashimoto’s thyroiditis with or without nodules at the first clinical evaluation and in the subsequent follow-up. 1.803
Differenze nella prevalenza del carcinoma papillare della tiroide (PTC) nei pazienti con noduli tiroidei (NT) associati a tiroidite di Hashimoto (HT) alla prima diagnosi rispetto ai pazienti con NT senza TH e ai pazienti con TH esordita prima dei NT. 1.795
Intraoperative parathyroid hormone assay during focused parathyroidectomy for primary hyperparathyroidism: is it really mandatory? 1.782
I noduli tiroidei e le tireopatie autoimmuni interferiscono con la scintigrafia sesta-MIBI e con l’ecografia nella localizzazione delle paratiroidi nell’iperparatiroidismo primitivo. 1.778
Hashimoto’s thyroiditis and thyroid cancer: a case-control study of unselected patients with thyroid nodules submitted to cytological and hystological examination. 1.758
Prevalence of overweight and obesity in Sardinian adolescents 1.750
Hypothyroidism and thyroid autoimmunity in metastatic renal cell carcinoma patients treated with sunitinib: 2 years follow-up of long survivors from a single centre experience. 1.720
null 1.717
High prevalence of autoimmune thyroid disease in thyroids with oncocytic tumors. 1.651
Asociation beween thyroid autoimmunità and papillary thyroid carcinoma: recent confirmation form a prospective study. 1.614
High prevalence of subclinical extraocular muscles alterations in graves’ disease patients asymptomatic for active graves’orbitopathy 1.604
HYPOTHALAMIC-Pituitary axis in aps i: novel autoantibody targets possibly related to endocrine disfunctions 1.587
Functioning glucagonoma associated with primary hyperparathyroidism: multiple endocrine neoplasia type 1 or incidental association? 1.585
Brain perfusion abnormalities showed by 99mTc-ECD SPECT in patients with autoimmune thyroid disorders 1.580
99mTc-Sestaminbi scan is not useful in the pre-surgical evaluation of thyroid nodules with oncocytic cytology. 1.544
Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function 1.515
Fibrinogen and D-dimer levels in autoimmune subclinical and overt hypothyroidism and effects of levothyroxine treatment. 1.506
null 1.503
99mTc-SESTAMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology. 1.499
The usefulness of calcitonin assay in fine needle aspiration biopsy (FNAB) fluid of neck masses of patients with primitive and metastatic medullary thyroid carcinoma (MTC). 1.492
Utilità dell’ecocolor Doppler nella diagnosi differenziale tra gozzo multinodulare tossico e variante multinodulare del morbo di Basedow. 1.467
Elevata prevalenza di alterazioni subcliniche dei muscoli extraoculari in pazienti con morbo di Basedow asintomatici per oftalmopatia attiva. 1.459
Ricerca della mutazione BRAFV600E e del riarrangiamento RET/PTC negli agoaspirati tiroidei in pazienti sardi 1.451
Classification and Etiopathogenesis of Hypothyroidism 1.451
Identificazione e uso di sonde molecolari per una migliore caratterizzazione pre-chirurgica dei noduli tiroidei 1.438
Functional characterization of aCDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 1.435
Value of thyroid echography in the long-term follow-up of lithium-treated patients 1.432
99mTc-SestaMIBI scintigraphy of thyroid gland in patient with primary hyperparathyroidism: unusual features due to coesistence of a thyroid papillary carcinoma 1.425
Coexistent thyroid pathology may impair parathyroid localization in primary hyperparathyroidism: usefulness of PTH assay in FNAB fluid wash-out. 1.376
null 1.334
99mTc-Sesta-MIBI thyroid scan in the differential diagnosis of amiodarone-induced thyrotoxicosis. 1.333
Identificazione e uso di sonde molecolari per una migliore caratterizzazione pre-chirurgica del noduli tiroidei. 1.328
Heterogeneity of thyroid function and impact of peripheral thyroxine deiodination in centenarians and semi-supercentenarians: association with functional status and mortality 1.310
Totale 251.660
Categoria #
all - tutte 450.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 450.978


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202067.615 0 2.061 522 1.413 26.483 18.670 9.744 2.241 1.340 1.367 1.421 2.353
2020/202190.907 2.906 3.283 3.496 24.011 17.939 10.695 7.943 5.591 2.271 5.009 4.442 3.321
2021/202219.562 2.304 1.740 1.176 1.523 1.735 1.501 1.284 1.005 1.499 1.617 2.159 2.019
2022/202329.516 2.309 3.062 2.893 2.252 2.329 2.553 1.637 3.186 2.457 2.086 2.856 1.896
2023/202438.480 2.403 1.706 1.867 2.709 3.353 4.983 5.325 3.254 2.226 3.004 3.828 3.822
2024/202529.833 25.696 4.137 0 0 0 0 0 0 0 0 0 0
Totale 367.204